Keyword: phenylbutazone

  • Trainer Brendan Walsh

    Trainer Walsh Says Mistake Led to Positive

    Trainer Brendan Walsh has sent a letter to his owners contending that a post-race test that found multiple non-steroidal anti-inflammatory drugs in Saham after a race was the result of a veterinarian's error.

  • Brendan Walsh

    Kentucky Trainer Walsh Suspended 10 Days

    Kentucky stewards have suspended trainer Brendan Walsh for 10 days after multiple non-steroidal anti-inflammatory drugs were found in post-race tests of Saham after his third-place finish in the Transylvania Stakes.

  • Iowa Stallion Rule Change Called Positive

    Iowa has removed a restriction requiring Iowa-registered stallions to be owned by in-state residents, and breeders believe the legislative change with foster growth in the program.

  • Kentucky HBPA 'Disappointed' With Override

    The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.

  • Purse Bonus for Field Size Gets Illinois OK

    The Illinois Racing Board agreed July 26 to require race tracks to include "field size bonus" money in the base purse amount used to calculate owners' and breeders' awards.

  • New York Revises Bute Administration Rule

    New York is returning to a standard banning the use of phenylbutazone in horses in the 48 hours leading up to a race. The state Racing and Wagering Board on Feb. 29 adopted a final rule revising the Bute time and threshold.

  • Romans to Begin 7-Day Suspension

    Trainer Dale Romans is to begin serving a seven-day suspension Feb. 13 stemming from a positive test on one of his horses for phenylbutazone after a race last November at Aqueduct, Daily Racing Form reports.

  • Approval of Bute Rule Slowed in Louisiana

    A Louisiana Senate committee rejected an emergency rule approved by the Louisiana State Racing Commission to lower the testing threshold level for phenylbutazone from 5 micrograms per milliliter to 2 micrograms.

  • CHRB OKs Lower Bute Level, Claiming Rule

    A reduction in the allowable level of the common pain reliever phenylbutazone in post-race tests was approved on a split vote by the California Horse Racing Board July 21 over the objections of horsemen.

  • CHRB Eyes Lower Phenylbutazone Threshold

    Lower thresholds for the pain reliever phenylbutazone, commonly known as Bute, in post-race tests of horses could be on the way in California in spite of objections from horsemen.

  • KY Drug Council Targets Corticosteroids

    The Kentucky Drug Equine Research Council, citing a need to explore use of corticosteroids in racehorses, agreed Feb. 9 to take bids for research into one of the drugs in the research planning phase.

  • RCI Board Votes to Lower Bute Threshold

    The Association of Racing Commissioners International board of directors voted Oct. 22 to lower the threshold level for phenylbutazone from five micrograms per milliliter of plasma or serum to two.

  • Upset Lingers Over Proposed Bute Regulation

    The largest horsemen's group in the country continues to call for the racing industry to perform thorough research before it continues with its plan to lower the testing threshold for phenylbutazone.

  • Model Rules Committee OKs New Bute Standard

    The Model Rules Committee of the Association of Racing Commissioners International has voted 12-0, with one abstention, to recommend lowering the threshold of the non-steroidal anti-inflammatory drug Phenylbutazone.

  • Officials Cite Progress Made in Drug Testing

    Laboratories that test samples for the presence of drugs in California, Delaware, Kentucky, New York, Pennsylvania, West Virginia, and other states have signed letters of intent to submit to accreditation.

  • RMTC Acts to Reduce Potential Impact of Bute

    The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.

  • Unreported Medications Found in Sale Horses

    Tests conducted on juveniles that participated in under-tack shows prior to the Ocala Breeders' Sales Co.'s March select auction did not detect any performance enhancing-drugs, but therapeutic medications were found in blood samples from three horses whose consignors had not reported the treatments, said Tom Ventura, general manager and director of sales for OBS.

  • New York Bill Would OK Race-Day Bute

    The use of phenylbutazone would be permitted on race days in New York under legislation recently proposed by Assemblyman Gary Pretlow, a Yonkers Raceway booster. In New York, the pain-killer can't be administered to a horse within 48 hours of a race.